COVID-19
Diagnostics for the Real World Prepares to Launch Retooled Rapid Point-of-Care Testing Platform
Premium
The company, also known as DRW, shared early data on its forthcoming multiplex qPCR-based platform and infectious disease panels at the ESCMID global congress in Vienna.
On the heels of CLIA waiver, the Austin, Texas-based firm aims to submit additional respiratory tests for regulatory clearance.
Severe COVID-19-Related Lung Damage Contributors Found in Postmortem Transcriptomic Study
Researchers used RNA sequencing and spatial transcriptomics to spell out cellular and molecular changes involved in early- and late-stage lung damage in severe COVID-19 cases.
Visby Medical Gains FDA 510(k) Clearance, CLIA Waiver for POC Respiratory Panel
The Visby Medical Respiratory Health Test is a disposable handheld RT-PCR-based assay for the detection and differentiation of SARS-CoV-2 and flu A/B.
The pharmaceutical firm said the decision was related to the cost associated with the molecular tests.
Oct 29, 2024
FDA Clears Qiagen QiaStat-Dx Respiratory Mini Panel
May 23, 2024